Abstract LB-100: Discovery of HM61713 as an orally available and mutant EGFR selective inhibitor
Article Details
- CitationCopy to clipboard
Kwang O-K, Cha MY, Kim M, Song JY, Lee J-H, Kim YH, Lee Y-M, Suh KH, Son J.
Abstract LB-100: Discovery of HM61713 as an orally available and mutant EGFR selective inhibitor
Cancer Res. 2014 October;74(19 Suppl.):Abstract nr LB-100.
- PubMed ID
- Not Available
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drugs
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Olmutinib Epidermal growth factor receptor Protein Humans YesInhibitorDetails